About Us

Caris Life Sciences™ is at the forefront of precision healthcare, helping patients and their physicians find the right treatment for cancer and other complex diseases. The company's areas of focus - anatomic pathology, molecular profiling, and cutting-edge Carisome™ microvesicle technology - combine current state-of-the-art testing methodologies with emerging and breakthrough technologies. Caris brings better outcomes to patients today and advances the frontier of what is possible tomorrow.

Together, these areas of focus aim to improve healthcare through innovation and quality. Precision diagnostic tests and services provide the intellectual foundation for rational treatment selection and the evolution of increasingly personalized approaches to disease management. Collectively, these trends will lower healthcare costs, focus the allocation of finite, expensive healthcare resources and, most important, improve health outcomes and quality of life for patients. These results earn Caris the privilege of serving as a trusted advisor to thousands of physicians across the country.

Caris is a privately-held leader in biosciences, headquartered in the Dallas-Fort Worth Metroplex, with U.S. operations in Phoenix, Arizona and Boston, Massachusetts and a globalization effort that has begun in Lausanne, Switzerland.